{"id":"https://openalex.org/W3087185067","doi":"https://doi.org/10.1158/1535-7163.mct-20-0229","title":"CH7233163 Overcomes Osimertinib-Resistant EGFR-Del19/T790M/C797S Mutation","display_name":"CH7233163 Overcomes Osimertinib-Resistant EGFR-Del19/T790M/C797S Mutation","alternate_titles":[],"publication_year":2020,"publication_date":"2020-11-01","ids":{"openalex":"https://openalex.org/W3087185067","doi":"https://doi.org/10.1158/1535-7163.mct-20-0229","mag":"3087185067","pmid":"https://pubmed.ncbi.nlm.nih.gov/32943545"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-20-0229","doi":"https://doi.org/10.1158/1535-7163.mct-20-0229","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-20-0229","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3087185067"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057149593","display_name":"Kenji Kashima","orcid":"https://orcid.org/0000-0001-8460-2102","observed_orcids":["https://orcid.org/0000-0001-8460-2102"]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kenji Kashima","raw_affiliation_strings":["Research Division, Chugai Pharmaceutical Co. Ltd., Kanagawa, Japan"],"raw_orcid":"https://orcid.org/0000-0001-8460-2102","affiliations":[{"raw_affiliation_string":"Research Division, Chugai Pharmaceutical Co. Ltd., Kanagawa, Japan","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047863859","display_name":"Hiroki Kawauchi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hiroki Kawauchi","raw_affiliation_strings":["Research Division, Chugai Pharmaceutical Co. Ltd., Kanagawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Division, Chugai Pharmaceutical Co. Ltd., Kanagawa, Japan","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110966917","display_name":"Hiromi Tanimura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hiromi Tanimura","raw_affiliation_strings":["Research Division, Chugai Pharmaceutical Co. Ltd., Kanagawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Division, Chugai Pharmaceutical Co. Ltd., Kanagawa, Japan","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110966918","display_name":"Yukako Tachibana","orcid":"https://orcid.org/0009-0009-5485-1381","observed_orcids":["https://orcid.org/0009-0009-5485-1381"]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yukako Tachibana","raw_affiliation_strings":["Research Division, Chugai Pharmaceutical Co. Ltd., Kanagawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Division, Chugai Pharmaceutical Co. Ltd., Kanagawa, Japan","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053863787","display_name":"Takashi Chiba","orcid":"https://orcid.org/0000-0001-6431-3645","observed_orcids":["https://orcid.org/0000-0001-6431-3645"]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Takashi Chiba","raw_affiliation_strings":["Research Division, Chugai Pharmaceutical Co. Ltd., Kanagawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Division, Chugai Pharmaceutical Co. Ltd., Kanagawa, Japan","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033748500","display_name":"Takuya Torizawa","orcid":"https://orcid.org/0000-0001-7537-6123","observed_orcids":["https://orcid.org/0000-0001-7537-6123"]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Takuya Torizawa","raw_affiliation_strings":["Research Division, Chugai Pharmaceutical Co. Ltd., Kanagawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Division, Chugai Pharmaceutical Co. Ltd., Kanagawa, Japan","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"last","author":{"id":null,"display_name":"Hiroshi Sakamoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hiroshi Sakamoto","raw_affiliation_strings":["Research Division, Chugai Pharmaceutical Co. Ltd., Kanagawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Division, Chugai Pharmaceutical Co. Ltd., Kanagawa, Japan","institution_ids":["https://openalex.org/I4405254473"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4405254473"],"apc_list":null,"apc_paid":null,"fwci":8.9449,"has_fulltext":false,"cited_by_count":213,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.98505727,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"19","issue":"11","first_page":"2288","last_page":"2297"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/osimertinib-resistance","display_name":"osimertinib resistance","score":0.9789999723434448},{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.7080000042915344},{"id":"https://openalex.org/keywords/egfr-t790m-mutation","display_name":"T790M mutation","score":0.859000027179718},{"id":"https://openalex.org/keywords/egfr-c797s-mutation","display_name":"C797S mutation","score":0.9940000176429749},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.8960000276565552},{"id":"https://openalex.org/keywords/atp-competitive-inhibitors","display_name":"ATP-competitive inhibitors","score":0.9290000200271606},{"id":"https://openalex.org/keywords/crystal-structure","display_name":"crystal structure","score":0.6700000166893005},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.7739999890327454}],"concepts":[{"id":"https://openalex.org/C2777626846","wikidata":"https://www.wikidata.org/wiki/Q21506464","display_name":"Osimertinib","level":5,"score":0.9160712957382202},{"id":"https://openalex.org/C2777930144","wikidata":"https://www.wikidata.org/wiki/Q25100112","display_name":"T790M","level":5,"score":0.6685240268707275},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.44848310947418213},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4339938759803772},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3429204225540161},{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.30266112089157104},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2997722029685974},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2804117798805237},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2712070345878601},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.1727278232574463},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.16818293929100037},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.09759378433227539}],"mesh":[{"descriptor_ui":"D000178","descriptor_name":"Acrylamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000483","descriptor_name":"Alleles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000814","descriptor_name":"Aniline Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001667","descriptor_name":"Binding, Competitive","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017384","descriptor_name":"Sequence Deletion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D019943","descriptor_name":"Amino Acid Substitution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020869","descriptor_name":"Gene Expression Profiling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056004","descriptor_name":"Molecular Dynamics Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D062105","descriptor_name":"Molecular Docking Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.mct-20-0229","doi":"https://doi.org/10.1158/1535-7163.mct-20-0229","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-20-0229","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:32943545","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32943545","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9476000070571899,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307779","display_name":"Roche","ror":"https://ror.org/00by1q217"},{"id":"https://openalex.org/F4320333003","display_name":"Chugai Pharmaceutical","ror":"https://ror.org/01vepzj85"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":52,"referenced_works":["https://openalex.org/W255996521","https://openalex.org/W1546552389","https://openalex.org/W1967394241","https://openalex.org/W1968430623","https://openalex.org/W1986412478","https://openalex.org/W2003984225","https://openalex.org/W2014582878","https://openalex.org/W2023273957","https://openalex.org/W2043696829","https://openalex.org/W2065293650","https://openalex.org/W2088540000","https://openalex.org/W2096064309","https://openalex.org/W2096198395","https://openalex.org/W2108921801","https://openalex.org/W2110466017","https://openalex.org/W2110808180","https://openalex.org/W2114622716","https://openalex.org/W2124026197","https://openalex.org/W2132157071","https://openalex.org/W2143660875","https://openalex.org/W2154149901","https://openalex.org/W2159013299","https://openalex.org/W2159211495","https://openalex.org/W2160982674","https://openalex.org/W2166084034","https://openalex.org/W2180229411","https://openalex.org/W2298324804","https://openalex.org/W2321260730","https://openalex.org/W2400274474","https://openalex.org/W2536396512","https://openalex.org/W2585341756","https://openalex.org/W2591118779","https://openalex.org/W2626282040","https://openalex.org/W2747965175","https://openalex.org/W2765322245","https://openalex.org/W2770828094","https://openalex.org/W2801052665","https://openalex.org/W2885289995","https://openalex.org/W2890442632","https://openalex.org/W2911247330","https://openalex.org/W2944732073","https://openalex.org/W2945712323","https://openalex.org/W2964827678","https://openalex.org/W2971229303","https://openalex.org/W2975117225","https://openalex.org/W2988192292","https://openalex.org/W2989251275","https://openalex.org/W3010996890","https://openalex.org/W3018637389","https://openalex.org/W4248872320","https://openalex.org/W4360790490","https://openalex.org/W7073696094"],"related_works":["https://openalex.org/W3053865085","https://openalex.org/W4282961077","https://openalex.org/W4282929350","https://openalex.org/W4313532692","https://openalex.org/W4282933481","https://openalex.org/W4362594113","https://openalex.org/W4393073293","https://openalex.org/W2964827678","https://openalex.org/W3165203146","https://openalex.org/W4410803029"],"abstract_inverted_index":{"Osimertinib":[0],"is":[1,106,135],"the":[2,52,75,118],"only":[3],"EGFR-tyrosine":[4],"kinase":[5],"inhibitor":[6,110],"(TKI)":[7],"capable":[8],"of":[9,86,146],"overcoming":[10],"EGFR-T790M\u2013mutated":[11],"NSCLC,":[12],"but":[13],"osimertinib-resistant":[14,141],"EGFR":[15,26,87],"triple":[16],"mutations":[17],"(Del19/T790M/C797S":[18],"or":[19],"L858R/T790M/C797S)":[20],"have":[21,34],"been":[22,35],"reported.":[23],"Although":[24],"allosteric":[25],"TKIs":[27],"(e.g.,":[28,89],"EAI-045)":[29],"that":[30,79,104,113,133],"potentially":[31,137],"overcome":[32,55],"L858R/T790M/C797S":[33],"identified,":[36],"there":[37],"are":[38],"no":[39],"effective":[40,138],"inhibitors":[41],"against":[42,62],"Del19/T790M/C797S.":[43],"In":[44,71],"this":[45],"study,":[46],"we":[47,131],"identified":[48],"CH7233163":[49,57,80,105,134],"as":[50],"having":[51],"potential":[53],"to":[54,73,122],"EGFR-Del19/T790M/C797S.":[56,147],"showed":[58,78],"potent":[59,124],"antitumor":[60],"activities":[61],"tumor":[63],"with":[64,117],"EGFR-Del19/T790M/C797S":[65,112],"in":[66,69,144],"vitro":[67],"and":[68,94,127],"vivo.":[70],"addition":[72],"EGFR-Del19/T790M/C797S,":[74],"characterization":[76],"assays":[77],"more":[81],"selectively":[82],"inhibits":[83],"various":[84],"types":[85],"mutants":[88],"L858R/T790M/C797S,":[90],"L858R/T790M,":[91],"Del19/T790M,":[92],"Del19,":[93],"L858R)":[95],"over":[96],"wild":[97],"type.":[98],"Furthermore,":[99],"crystal":[100],"structure":[101],"analysis":[102],"suggested":[103],"a":[107,136],"noncovalent":[108],"ATP-competitive":[109],"for":[111,140],"utilizes":[114],"multiple":[115],"interactions":[116],"EGFR's":[119],"\u03b1C-helix-in":[120],"conformation":[121],"achieve":[123],"inhibitory":[125],"activity":[126],"mutant":[128],"selectivity.":[129],"Therefore,":[130],"conclude":[132],"therapy":[139],"patients,":[142],"especially":[143],"cases":[145]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3087185067","counts_by_year":[{"year":2026,"cited_by_count":41},{"year":2025,"cited_by_count":37},{"year":2024,"cited_by_count":51},{"year":2023,"cited_by_count":36},{"year":2022,"cited_by_count":34},{"year":2021,"cited_by_count":14}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2020-09-25T00:00:00"}
